Medications

New formulation yields potential long-term HIV protection

For people at high risk of contracting HIV, missing doses of their daily HIV prevention pills can have big consequences. In some cases, missing a pill can lead to lack of protection against the virus.

Oncology & Cancer

Preventing cervical cancer

Silent but deadly. These are words often used to describe cervical cancer—a slow-growing disease that rarely causes symptoms in its early stages.

Medications

FDA approves Sunlenca for treatment-resistant HIV

The U.S. Food and Drug Administration has approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with HIV-1 whose HIV infection cannot be successfully treated with other available ...

HIV & AIDS

Task force recommends PrEP for reducing risk for HIV acquisition

The U.S. Preventive Services Task Force (USPSTF) recommends preexposure prophylaxis (PrEP) for reducing the risk for HIV infection among individuals at increased risk for HIV acquisition. This recommendation forms the basis ...

page 7 from 40